Every Thursday we send out a curated newsletter on all things femtech and women’s health innovation. This is an excerpt from the latest edition. If you’d like to subscribe, you can do so at the bottom of this page.
Highlights
Reproductive health company Twentyeight Health acquires competitor SimpleHealth.
Canadian DTC telehealth startup Felix adds $10M in Series A funding to expand its care offering.
Medherant raises £3M to kick off clinical trials for its novel menopause hormone patch.
Consumer biotech company Tally Health raises $10M for its platform aimed at extending longevity.
Mitera launches a new certification program to raise medical standards across thrid party reproduction.
In the Know
Founder Q&A with Toyosi Babalola: How Abulé Is Transforming Caregiving with Community-Driven, Value-Based Care (Femtech Insider)
Meet 13 startups from Y Combinator‘s W23 batch we’re watching closely right now
Women and Leadership in Global Health – Where Do We Stand Now? (Forbes)
Women’s health – doctor doesn’t always know best (Financial Times)
Birth control fail: Why American women can’t have better contraceptives in 2023 (Fortune)
15 Femtech Startups to Watch (betahaus)
Sweeping new study analyzes maternal health outcomes with SDOH, finds Black mothers at much higher risk (Fierce Healthcare)
Women in the healthcare industry: An update (McKinsey)
